Impact of <scp>COVID</scp> ‐19 on respiratory function testing in Australian laboratories
Our analysis highlights the substantial impact that the COVID-19 pandemic had on laboratory-based Medicare-funded respiratory function testing in Australia. State-based fluctuations in testing numbers suggest the need for similar analysis elsewhere to fully understand the impact that COVID-19 had on respiratory laboratories worldwide.
Authors
- T Churchward (ORCID: https://orcid.org/0000-0003-1471-9318)
- Charlotte Lanteri
- Warren R. Ruehland (ORCID: https://orcid.org/0000-0001-9626-7460)
- Danny J. Brazzale (ORCID: https://orcid.org/0009-0007-5148-2969)
- Christine F. McDonald (ORCID: https://orcid.org/0000-0001-6481-3391)
- Edward K. Smith (ORCID: https://orcid.org/0009-0007-1956-4518)
Institutions
- The University of Melbourne (AU)
- Institute for Breathing and Sleep (AU)
- Austin Health (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/imj.70278
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lung Foundation Australia
- Medical Research Council
- National Health and Medical Research Council